Infergen and Effexor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Infergen (interferon alfacon-1) and Effexor (venlafaxine hydrochloride). Common drug interactions include vomiting among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Infergen and Effexor. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Infergen?

Infergen has active ingredients of interferon alfacon-1. eHealthMe is studying from 766 Infergen users. Check the latest studies of Infergen.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

30 people who take Infergen and Effexor together, and have interactions are studied.

Infergen and Effexor drug interactions.

What are the common drug interactions of Infergen and Effexor, by gender? *:

female:

  1. Vomiting
  2. Weight decreased
  3. Ammonia increased
  4. Balance disorder
  5. Blood potassium decreased
  6. Cough
  7. Dry eye (lack of adequate tears)
  8. Dry mouth
  9. Dry skin
  10. Fibromyalgia (a long-term condition which causes pain all over the body)

male:

  1. Anaemia (lack of blood)
  2. Abnormal behaviour
  3. Cellulitis (infection under the skin)
  4. Coma (state of unconsciousness lasting more than six hours)
  5. Confusional state
  6. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  7. Dyskinesia (abnormality or impairment of voluntary movement)
  8. Dyspnoea (difficult or laboured respiration)
  9. Haematocrit decreased
  10. Haemoglobin decreased

What are the common drug interactions of Infergen and Effexor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abnormal behaviour
  2. Anaemia (lack of blood)
  3. Catatonia (unresponsive to external stimuli)
  4. Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
  5. Panic attack
  6. Bipolar disorder (mood disorder)
  7. Blood creatine phosphokinase increased
  8. Blood thyroid stimulating hormone increased
  9. Cellulitis (infection under the skin)
  10. Coma (state of unconsciousness lasting more than six hours)

50-59:

  1. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  2. Peripheral coldness
  3. Restlessness (not able to rest)
  4. Road traffic accident
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Tooth disorder (tooth disease)
  7. Urinary tract infection
  8. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  9. Nausea (feeling of having an urge to vomit)
  10. Asthenia (weakness)

60+:

  1. Anaemia (lack of blood)
  2. Arthralgia (joint pain)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Headache (pain in head)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Insomnia (sleeplessness)
  7. Myalgia (muscle pain)
  8. Nausea (feeling of having an urge to vomit)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

What are the existing conditions these people have? *

  1. Hepatitis C: 24 people, 80.00%

* Approximation only. Some reports may have incomplete information.

Do you take Infergen and Effexor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Infergen and Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Infergen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Infergen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on interferon alfacon-1 and venlafaxine hydrochloride (the active ingredients of Infergen and Effexor, respectively), and Infergen and Effexor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: